Team:Goettingen/HumanPractice/Overview

From 2013.igem.org

(Difference between revisions)
(Our Human Practice)
(Our Human Practice)
Line 23: Line 23:
</html>
</html>
===Our Human Practice===
===Our Human Practice===
-
<html>
+
In terms of “human practice” the iGEM Team Göttingen invited for a panel discussion.  
-
<p>In terms of “human practice” the iGEM Team Göttingen invited for a panel discussion.  
+
 
At the 12th of June 2013 the historical observatory in Göttingen was the perfect scenery to present our project “The beast and its Achilles heel: A novel target to fight multi-resistant pathogenic bacteria” and of course to discuss urgent topics like the origin, development and fighting of multi-resistant bacteria as well as gene technology.
At the 12th of June 2013 the historical observatory in Göttingen was the perfect scenery to present our project “The beast and its Achilles heel: A novel target to fight multi-resistant pathogenic bacteria” and of course to discuss urgent topics like the origin, development and fighting of multi-resistant bacteria as well as gene technology.
-
After an introducing presentation dealing with the iGEM competition itself and the general description of our project we reconciled to the actual panel discussion. </p>
+
 
-
<p>Therefore we were honored to introduce the following guests: </p>
+
After a brief introduction concerning  the iGEM competition itself followed by  the general description of our project we reconciled to the actual panel discussion.  
-
</html>
+
 
 +
Therefore we were honored to introduce the following guests:
 +
 
=== ===
=== ===
<html>
<html>

Revision as of 14:26, 28 September 2013





The beast and its Achilles heel:

 A novel target to fight multi-resistant pathogenic bacteria


Our Human Practice

In terms of “human practice” the iGEM Team Göttingen invited for a panel discussion.

At the 12th of June 2013 the historical observatory in Göttingen was the perfect scenery to present our project “The beast and its Achilles heel: A novel target to fight multi-resistant pathogenic bacteria” and of course to discuss urgent topics like the origin, development and fighting of multi-resistant bacteria as well as gene technology.

After a brief introduction concerning the iGEM competition itself followed by the general description of our project we reconciled to the actual panel discussion.

Therefore we were honored to introduce the following guests: